スポンサーリンク
Department of Immunology, Osaka Medical Center for Cancer and Cardiovascular Diseases | 論文
- Innate Immune Therapy with a Bacillus Calmette-Guerin Cell Wall Skeleton After Radical Surgery for Non-Small Cell Lung Cancer : A Case-Control Study
- The expression of a novel natural killer inhibitory molecule, Cho-1, on the chorionic cytotrophoblast cells of successful pregnancy, but not of spontaneous abortion
- A Novel Negative Regulator Molecule, Cho-1, Is Involved in the Cytotoxicity by Human Natural Killer Cells but Not in Cytotoxic T Lymphocytes
- A Wild-type Japanese Measles Virus Strain Inducing Predominant Early Down-regulation of CD46
- Molecular Cloning of a Complementary DNA for a Membrane Cofactor Protein (MCP, CD46)/Measles Virus Receptor on Vero Cells and Its Functional Characterization
- The cytoplasmic 'linker region' in Toll-like receptor 3 controls receptor localization and signaling
- Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection
- NK-activating dendritic cells are elicited by stimulation with Toll-like receptor 3
- Adjuvant engineering for cancer immunotherapy : Development of a synthetic TLR2 ligand with increased cell adhesion
- Reversible force transduction in tendrils of Passiflora coerulea
- Enhancement of antitumor natural killer cell activation by orally administered Spirulina extract in mice
- Ligation of Human CD46 with Purified Complement C3b or F(ab')_2 of Monoclonal Antibodies Enhances Isoform-Specific Interferon Gamma-Dependent Nitric Oxide Production in Macrophages
- Three Soluble Form Messages of Murine CD46 Are Produced through Alternative mRNA Splicing
- Molecular cloning and functional characterization of guinea pig IL-12
- Involvement of ST6Gal I in the biosynthesis of a unique human colon cancer biomarker candidate, α2,6-sialylated blood group type 2H (ST2H) antigen
- Transforming potential of c-erbB-2 gene that encodes an novel growth factor receptor
- Three Soluble Form Messages of Murine CD46 Are Produced through Alternative mRNA Splicing.